Latest Breaking News On - Christoph tausch - Page 1 : vimarsana.com

Mediclinic Middle East has launched a collaborative clinical trial with its sister Mediclinic division in Switzerland, Hirslanden. In the first collaboration of its kind – led by Principal Investigator Dr Annett Hamadi, Consultant General and Breast Surgeon at Mediclinic City Hospital in Dubai, and Professor Christoph Tausch, Coordinating Investigator from Hirslanden’s Breast Centre in Zurich – the groundbreaking project will investigate whether imaging and intelligent vacuum-assisted biopsy of tissue are sufficient to determine the effectiveness of chemotherapy performed prior to tumour surgery in individuals with breast cancer, and whether a complete remission can be predicted in some patients using these techniques, meaning they would be able to avoid surgery. The results from this trial will help improve treatment strategies for patients suffering with breast cancer. The study will be conducted among 420 patients in the UAE, Switzerland, Austria and Germany, until the end of

United arab emiratesAnnett hamadiAbu dhabiChristoph tauschHirslanden breast centre in zurichImage creditMiddle eastPrincipal investigator dr annett hamadiConsultant generalBreast surgeonMediclinic city hospitalProfessor christoph tauschCoordinating investigatorBreast centreComprehensive cancer centresMediclinic airport road hospital